UCA1 and colorectal carcinoma: Exosomal lncRNA-UCA1 has been shown by Yang et al. to be capable of transmitting cetuximab resistance to susceptible CRC cells, and its expression is strongly associated with cetuximab treatment in CRC patients (Luan et al., 2020).